Zelira Therapeutics Limited (ZLDAF)
USD 0.35
(0.0%)
USD 0.35
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.38 Million | -7.24 Million | -9.42 Million | -8.61 Million | -6.93 Million | -3.34 Million |
| Net Income | -36.56 Million | -5.57 Million | -11.94 Million | -8.54 Million | -7.01 Million | -3.56 Million |
| Depreciation & Amortization | 479.03 Thousand | 545.22 Thousand | 588.54 Thousand | 474.25 Thousand | 275.05 Thousand | - |
| Deferred income taxes | - | -404.81 Thousand | -2.69 Million | -1.3 Million | -538.97 Thousand | - |
| Stock-based compensation | 35.77 Thousand | 404.81 Thousand | 2.69 Million | 1.3 Million | 538.97 Thousand | 462.19 Thousand |
| Change in working capital | 64.19 Thousand | 863.32 Thousand | -685.47 Thousand | -557.89 Thousand | -134.36 Thousand | 342.64 Thousand |
| Other non-cash items | 31.6 Million | -3.48 Million | -76.69 Thousand | -1.28 Million | -600.89 Thousand | -581.26 Thousand |
| Investing Cash Flow | 919.73 Thousand | 2.82 Million | -207.78 Thousand | 1.37 Million | 1.1 Million | 731.62 Thousand |
| Investments in PPE | - | - | - | - | -15.96 Thousand | -28.22 Thousand |
| Acquisitions | - | - | - | - | 189.78 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 736.43 Thousand | - | - | - | - |
| Other Investing Activities | 919.73 Thousand | 2.09 Million | -207.78 Thousand | 1.37 Million | 932.74 Thousand | 759.84 Thousand |
| Financing Cash Flow | 3.92 Million | 1.77 Million | 7.09 Million | 10.53 Million | 4.5 Million | - |
| Debt repayment | -3.92 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -88 Thousand | -286.7 Thousand | - |
| Common Stock Issuance | - | 1.77 Million | 7.09 Million | 10.61 Million | 4.78 Million | - |
| Other Financing Activities | 3.92 Million | 1.77 Million | 7.09 Million | 10.53 Million | 4.5 Million | - |
| Accounts receivables | -211.49 Thousand | 275.85 Thousand | -120.97 Thousand | -115.9 Thousand | -84.25 Thousand | 39.63 Thousand |
| Accounts payables | 1.66 Million | 230.96 Thousand | 525.06 Thousand | 425.59 Thousand | -50.11 Thousand | 303.01 Thousand |
| Inventory | 275.68 Thousand | 356.51 Thousand | -1.08 Million | -867.58 Thousand | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | -15.22 Thousand | 2.74 Million | 4.97 Million | 1.69 Million | 3.07 Million | 5.68 Million |
| Cash at end of period | 586.16 Thousand | 146.2 Thousand | 2.74 Million | 4.97 Million | 1.69 Million | 3.07 Million |
| Capital Expenditure | - | - | - | - | -15.96 Thousand | -28.22 Thousand |
| Effect of forex changes on cash | 146.2 Thousand | 49.6 Thousand | 310.7 Thousand | -18.99 Thousand | -48.67 Thousand | - |
| Net cash flow / Change in cash | 601.38 Thousand | -2.6 Million | -2.22 Million | 3.27 Million | -1.37 Million | -2.61 Million |
| Free Cash Flow | -4.38 Million | -7.24 Million | -9.42 Million | -8.61 Million | -6.95 Million | -3.37 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.21 Million | -36.56 Million | -1.21 Million | -34.13 Million | -17.06 Million | -5.57 Million |
| Depreciation & Amortization | 101.28 Thousand | 479.03 Thousand | 101.28 Thousand | 276.47 Thousand | 138.23 Thousand | 545.22 Thousand |
| Deferred income taxes | - | - | - | - | - | -404.81 Thousand |
| Stock-based compensation | -96.61 Thousand | - | -96.61 Thousand | 114.5 Thousand | 114.5 Thousand | 404.81 Thousand |
| Change in working capital | 32.09 Thousand | 1.73 Million | 32.09 Thousand | - | - | 863.32 Thousand |
| Other non-cash items | -147.85 Thousand | 29.19 Million | -147.85 Thousand | 32.67 Million | 15.94 Million | -3.48 Million |
| Investing Cash Flow | 459.86 Thousand | 919.73 Thousand | 459.86 Thousand | -6417.00 | - | 2.82 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 736.43 Thousand |
| Other Investing Activities | 459.86 Thousand | 919.73 Thousand | 459.86 Thousand | - | - | 2.09 Million |
| Financing Cash Flow | 1.13 Million | 3.92 Million | 1.13 Million | 1.66 Million | 831.9 Thousand | 1.77 Million |
| Debt repayment | -2.26 Million | -3.92 Million | - | -1.66 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 1.77 Million |
| Other Financing Activities | 1.13 Million | - | 1.13 Million | 831.9 Thousand | 831.9 Thousand | 1.77 Million |
| Accounts receivables | -105.74 Thousand | -211.49 Thousand | -105.74 Thousand | - | - | 275.85 Thousand |
| Accounts payables | - | 1.66 Million | - | - | - | 230.96 Thousand |
| Inventory | 137.84 Thousand | 275.68 Thousand | 137.84 Thousand | - | - | 356.51 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 64.83 Thousand | 146.2 Thousand | - | 146.2 Thousand | - | 2.74 Million |
| Cash at end of period | 586.16 Thousand | 586.16 Thousand | 260.66 Thousand | 64.83 Thousand | -40.68 Thousand | 146.2 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -1195.00 | - | -1195.00 | -6417.00 | -6417.00 | 49.6 Thousand |
| Net cash flow / Change in cash | 521.32 Thousand | 439.95 Thousand | 260.66 Thousand | -81.37 Thousand | -40.68 Thousand | -2.6 Million |
| Free Cash Flow | -1.32 Million | -4.38 Million | -1.32 Million | -1.73 Million | -866.17 Thousand | -7.24 Million |
0682
ALSAU
000036
0QT0
LEIC
AACT